Viewing Study NCT02899169


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2026-01-02 @ 11:34 AM
Study NCT ID: NCT02899169
Status: UNKNOWN
Last Update Posted: 2021-09-08
First Post: 2016-09-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF)
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module